Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation

Circulation

Volumn 96, Issue 10, 1997, Pages 3281-3286

  Murata, Mitsuru ^a   Matsubara, Yumiko ^a   Kawano, Koichi ^b   Zama, Takeru ^a   Aoki, Nobuo ^b   Yoshino, Hideaki ^b   Watanabe, Gentaro ^c   Ishikawa, Kyozo ^b   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c Medical Center   (Japan)

Author keywords

Coronary disease; Genetics; Glycoproteins; Platelets; Risk factors

Indexed keywords

ANTITHROMBOCYTIC AGENT; GLYCOPROTEIN IB; GLYCOPROTEIN IX; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ALLELE; ALPHA CHAIN; AMINO ACID SEQUENCE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; ELECTROCARDIOGRAM; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SHEAR STRESS; TANDEM REPEAT; THROMBOCYTE ACTIVATION;

EID: 0030731403     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3281     Document Type: Article

References (35)

1. Mandelkorn JB, Wolf NM, Singh S, Shechter JA, Kersh RI, Rodgers DM, Workman MB, Bentivoglio LB, Laporte SM, Meister SG. Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol. 1983; 52:1-6.
2. Sherman CT, Litvack F, Grundfest W, Lee M, Hickey A, Chaux A, Kass R, Blanche C, Matloff J, Morgenstern L, Ganz W, Swan HJC, Forrester J. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med. 1986;315:913-919.
3. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary artery disease. N Engl J Med. 1986;315:983-989.
4. Trip MD, Manger Cats V, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990;322:1549-1554.
5. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohen PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613-617.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;356:242-250.
7. Goldberg ID, Stemerrnan MB. Vascular permeation of platelet factor-4 after endothelial injury. Science. 1980;209:611-612.
8. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol. 1991;17:77B-88B.
9. Peterson DM, Stathopoulos NA, Giorgio TD, Hellumus JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet glycoproteins Ib and IIb-IIIa. Blood. 1987;69:625-628.
10. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234-1240.
11. Weiss HJ. Flow-related platelet deposition on subendothelium. Thromb Haemost. 1995;74:117-122.
12. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moak JL. Platelets and shear stress. Blood. 1996;88:1525-1541.
13. Roth GJ. Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood. 1991;77:5-19.
14. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis. 1994;5:97-119.
15. Ikeda Y, Handa M, Kamata T, Kawano K, Kawai Y, Watanabe K, Kawakami K, Sakai K, Fukuyama M, Itagaki I, Yoshioka A, Ruggeri ZM. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost. 1993;69:496-502.
16. Chow TW, Hellums JD, Moake KL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80:113-120.
17. Kroll MH, Hellums JD, Guo Z, Durante W, Razdan K, Hrbolich JK, Schafer AI. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem. 1993;268:3520-3524.
18. Nichols TC, Bellinger DA, Johnson TA, Lamb MA, Griggs TR. von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circ Res. 1986;59:15-26.
19. Nichols TC, Bellinger DA, Reddick RL, Read MS, Koch GG, Brinkhous KM Griggs TR. Role of von Willebrand factor in arterial thrombosis. Circulation. 1991;83(suppl IV):IV-56-IV-64.
20. Strony J, Phillips M, Brands D, Moake J, Adelman B. Aurintricarboxylic acid in a canine model of coronary artery thrombosis. Circulation. 1990;81:1106-1114.
21. Yao SK, Ober JC, Garfinkel LI, Hagay Y, Ezov N, Ferguson JJ, Anderson HV, Panel A, Gorecki M, Buja LM, Willerson JT. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation. 1994;89:2822-2828.
22. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:351-355.
23. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
24. 145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest. 1992;89:381-384.
25. Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggeri ZM. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness. Blood. 1992;79:3086-3090.
26. Moroi M, Jung SM, Yoshida N. Genetic polymorphism of platelet glycoprotein Ib. Blood. 1984;64:622-629.
27. Wenger RH, Kieffer AN, Wicki N, Clemetson KJ. Structure of the human platelet membrane glycoprotein Ibα gene. Biochem Biophys Res Commun. 1988;156:389-395.
28. 145. Blood. 1995;86:1356-1360.
29. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.
30. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryocytes. Nucleic Acids Res. 1976;3:2303-2308.
31. Legler TJ, Kohler M, Mayr WR, Panzer S, Ohio H, Fischer GF. Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion. 1996;36:426-431.
32. Nurden AT. Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost. 1995;74:345-351.
33. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334:1090-1094.
34. Marian AJ, Brugada R, Kleinman NS. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med. 1996;335:1071-1072.
35. Osborn SV, Hampton KK, Smillie D, Channer KS, Daly ME. Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet. 1996;348:1309-1310.